Telix Pharmaceuticals financials at a glance
| Year | Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.20M | $3.49M | $5.21M | $7.60M | $160.10M | $502.55M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 100.00% | 27.03% | 61.17% | 66.46% | 61.55% | 62.56% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -45.71% | 10.32% | 0.00% |
| EPS | Earnings Per Share |
|
$-0.05 | $-0.07 | $-0.12 | $-0.17 | $-0.29 | $-0.28 | $0.12 | $0.00 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | 0.00% | 0 |
| Sha. | Shares |
|
197.44m | 218.37m | 253.28m | 280.41m | 280.41m | 308.2m | 0m | 323.98m |
| OCF | Operating Cash Flow |
|
$-6.03M | $-20.75M | $-23.33M | $1.96M | $-59.33M | $-63.97M | $23.88M | $0.00M |
| FCF | Free Cash Flow |
|
$-6.04M | $0.00M | $-23.73M | $1.71M | $-62.05M | $-73.17M | $47.63M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.05 | $-0.10 | $-0.10 | $0.01 | $-0.21 | $-0.25 | $0.04 | $0.00 |